RV
Rachel Vatnsdal JP Morgan Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
16
Avg Return
Past Year
Past Year
25%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
50%
Neutral
37.5%
Negative
12.5%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Materials
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Health Information Services
Medical Devices
Medical Distribution
Medical Instruments & Supplies
Materials
Specialty Chemicals
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $20 |
27%
upside
| 2 | +24% |
0
%
| 6 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $76 |
2%
downside
| 1 | +17% |
0
%
| 7 Aug ‘25 5 months ago |
|
|
|
Overweight
Maintained
| $14 |
13%
upside
| 1 | +9.2% |
0
%
| 4 Aug ‘25 5 months ago |
|
|
|
Overweight
Initiated
| $31 |
9%
upside
| 1 | +7.5% |
0
%
| 14 Jul ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $9 |
56%
downside
| 2 | – |
–
| 9 May ‘25 8 months ago |
|
|
|
Underweight
Maintained
| $33 |
7%
downside
| 2 | +17% |
0
%
| 6 May ‘25 8 months ago |
|
|
|
Overweight
Maintained
| $190 |
14%
upside
| 2 | +2.2% |
0
%
| 29 Apr ‘25 8 months ago |
|
|
|
Neutral
Maintained
| $100 |
4%
downside
| 1 | – |
–
| 29 Apr ‘25 8 months ago |
|
|
|
Neutral
Maintained
| $19 |
20%
downside
| 1 | – |
–
| 6 Mar ‘25 10 months ago |
|
|
|
Neutral
Maintained
| $390 |
2%
downside
| 1 | – |
–
| 6 Mar ‘25 10 months ago |
|
|
|
Neutral
Downgraded
| $55 |
17%
downside
| 1 | – |
–
| 25 Feb ‘25 10 months ago |
|
|
|
Overweight
Maintained
| $55 |
50%
downside
| 1 | +132% |
0
%
| 21 Feb ‘25 10 months ago |
|